Earlier this week Sterigenics International, LLC announced its acquisition of Nelson Laboratories, Inc. Private equity firms Warburg Pincus, LLC and GTCR were also involved in the transaction, the terms of which have not been disclosed.
As the largest U.S. provider of lifecycle microbiology testing services in the medical device, pharmaceutical and tissue industries, Nelson Labs has 570 employees (more than 300 are scientists and 60 microbiologists). The company operates 85 labs out of five buildings in Salt Lake City and will remain in its current location. Sterigenics’ microbiological and analytical testing services will be combined with Nelson Labs, creating the largest fully integrated sterilization and lab services firm worldwide, according to a press release from Sterigenics.
The combined entities will use the Nelson Labs name in the market and operate as a standalone business unit within Sterigenics.
Related Articles
-
Standalone best-of-breed Enterprise Asset Management (EAM) systems have historically been leveraged to help solve the transactional needs of clinical engineering, IT and facilities. Yet few organizations are currently capitalizing on the wealth of data generated from these systems. In this…
-
“We are excited to combine Bomi’s talent, expertise and capabilities with UPS Healthcare—together, we will provide unmatched solutions to our customers, powered by UPS’s integrated, global smart logistics network.”
-
CVS Health has entered into a definitive agreement to acquire Signify Health, which boasts a network of more than 10,000 physicians, nurse practitioners and physician assistants that provide home-based visits.
-
It is more important than ever for medical manufacturers to prepare for business interruption due to unexpected damage or natural disasters. From building a recovery team to securing proper insurance, there are many steps device manufacturers can take to recover…
